State Board of Administration of Florida Retirement System Sells 50 Shares of Inspire Medical Systems,

Trending News ☀️

Inspire Medical Systems ($NYSE:INSP), Inc. is a company that develops, manufactures, and markets implantable neurostimulation systems to treat obstructive sleep apnea and chronic pain. The State Board of Administration of Florida Retirement System has sold 50 shares of Inspire Medical Systems, Inc. The sale was disclosed in a filing with the Securities & Exchange Commission.

Market Price

At the time of writing, media sentiment towards INSPIRE was mostly positive. INSPIRE’s stock opened at $212.6 on Friday and closed at $212.5, down by 0.7% from its prior closing price of $214.0.

VI Analysis

Fundamentals are important for investors to consider when determining a company’s long term potential. The VI app makes it easy to see a company’s key fundamentals and how they reflect its potential. According to the VI Star Chart, INSPIRE MEDICAL SYSTEMS has an intermediate health score of 4/10 due to its cashflows and debt. This indicates that the company is likely to be able to sustain future operations in times of crisis.

However, the company is weak in terms of dividend and profitability. INSPIRE MEDICAL SYSTEMS is classified as a ‘cheetah’ company, which means it has achieved high revenue or earnings growth but is considered less stable due to lower profitability. This makes it a risky investment for some, but could be attractive to investors who are willing to take on more risk for the potential of high returns.

VI Peers

The company’s competitors include ShockWave Medical Inc, InMode Ltd, and INVO Bioscience Inc.

– ShockWave Medical Inc ($NASDAQ:SWAV)

ShockWave Medical Inc is a medical device company that uses shockwave technology to treat cardiovascular disease. The company has a market cap of 9.73B as of 2022 and a return on equity of 19.56%. The company’s products are used to treat a variety of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and heart failure.

– InMode Ltd ($NASDAQ:INMD)

InMode Ltd is a medical technology company that develops and manufactures minimally invasive aesthetic solutions. The company has a market capitalization of $2.71 billion as of 2022 and a return on equity of 41.58%. InMode’s products are used by physicians and patients in over 90 countries and the company has a strong presence in the United States, Europe, Asia, and Latin America. InMode’s products are backed by clinical research and have been featured in numerous peer-reviewed journals.

– INVO Bioscience Inc ($NASDAQ:INVO)

INVO Bioscience Inc is a medical device company that has developed a patented in vivo intravaginal culture (IVC) system, which is used to treat infertility. The company’s IVC system is designed to provide a more natural environment for embryo development and is intended to improve the success rates of in vitro fertilization (IVF). INVO Bioscience’s IVC system is currently being used at fertility clinics in the United States and Europe.

Summary

Inspire Medical Systems, Inc. is a medical technology company. The Company offers a neurostimulation platform that provides a less invasive and more patient-friendly alternative to traditional treatments for obstructive sleep apnea (OSA). The Company’s platform is based on the premise that stimulating the hypoglossal nerve controls the muscles of the upper airway, and that by doing so, the airway is kept open during sleep. The Company’s proprietary neurostimulation system is commercially available in the United States and Europe, and is currently being studied in clinical trials in Asia.